(Q35143094)

6 August 2017

1 reference

title

Immunomodulatory effects of quinolones (English)

1 reference

6 August 2017

0 references

Axel Dalhoff

1

1 reference

6 August 2017

Itamar Shalit

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2003

1 reference

Lancet Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

359-371

1 reference

Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of quinolones on intestinal ecology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunity and probiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Antibiotics and Phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Intracellular distribution and activity of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunomodulation by macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunomodulating activity of quinolones: review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Selective enhancement of synthesis of interleukin-2 in lymphocytes in the presence of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Fluoroquinolone resistance among Gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Possible interaction between new quinolones and immune functions in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Comparative studies of modulatory effect to the function of rat peritoneal neutrophils treated with new quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Fluorinated 4-quinolones induce hyperproduction of interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of trovafloxacin on production of cytokines by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Protection against lipopolysaccharide-induced death by fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Evidence that the antibiotic ciprofloxacin counteracts cyclosporine-dependent suppression of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Comparative effects of quinolones on human mononuclear leucocyte functions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effects of quinolones on interleukin 1 production in vitro by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Interleukin-1 production by antibiotic-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Quinolone-induced differential modification of IL-1 alpha and IL-1 beta production by LPS-stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin enhances T cell function by modulating interleukin activities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunological aspects of new quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Intrapulmonary concentrations of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of rufloxacin on in-vitro proliferation and differentiation of human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effects of fleroxacin on HeLa cell functions and topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of grepafloxacin on cytokine production in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effects of quinolones on tumor necrosis factor production by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Gram-positive and gram-negative bacteria do not trigger monocytic cytokine production through similar intracellular pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Impact of different classes antimicrobial agents on plasma endotoxin activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Lack of interaction of fluoroquinolones with lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Evaluation of temafloxacin in a rat model of intra-abdominal abscess

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Comparative in vitro activity of gemifloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin affects pregnancy loss in CBA/JxDBA/2J mice possibly via elevation of interleukin-3 and granulocyte macrophage-colony stimulating factor production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of fluoroquinolones on the in-vitro proliferation of myeloid precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Influence of two quinolones, ofloxacin and pefloxacin, on human myelopoiesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Interleukin-3 and pregnancy loss in antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of short-term therapy with ciprofloxacin, ceftriaxone and placebo on human peripheral WBC and marrow-derived granulocyte-macrophage progenitor cells (CFU-GM)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Effect of ciprofloxacin on hematologic parameters in breast cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Medical therapy for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

New quinolones: in vitro effects as a potential source of clinical toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Modulation of the production of cytokines in titanium-stimulated human peripheral blood monocytes by pharmacological agents. The role of cAMP-mediated signaling mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Enhancement of superoxide production of polymorphonuclear neutrophils by ofloxacin and the effects of the inhibitors of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Ciprofloxacin inhibits activation of latent human immunodeficiency virus type 1 in chronically infected promonocytic U1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Fleroxacin enhancement of superoxide production by polymorphonuclear leukocytes: the role of protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

Priming by grepafloxacin on respiratory burst of human neutrophils: its possible mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900658-3

7 January 2021

10.1016/S1473-3099(03)00658-3

Identifiers

DOI

1 reference

6 August 2017

1 reference